Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Effect of galectin-1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma.
Cancer Med. 2024 Apr;13(7):e7113. doi: 10.1002/cam4.7113.
Cancer Med. 2024.
PMID: 38545824
Free PMC article.
Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma.
Xu Z, Jiang W, Liu L, Qiu Y, Wang J, Dai S, Guo J, Xu J.
Xu Z, et al.
Cancer Immunol Immunother. 2024 Apr 12;73(5):95. doi: 10.1007/s00262-024-03681-x.
Cancer Immunol Immunother. 2024.
PMID: 38607586
Free PMC article.
Item in Clipboard
Effect of Annexin A2 on prognosis and sensitivity to immune checkpoint plus tyrosine kinase inhibition in metastatic renal cell carcinoma.
Wang J, Lin J, Wang J, Wang Y, Zhu Y, Xu X, Guo J.
Wang J, et al.
Discov Oncol. 2024 Mar 22;15(1):86. doi: 10.1007/s12672-024-00934-0.
Discov Oncol. 2024.
PMID: 38519766
Free PMC article.
Item in Clipboard
Cite
Cite